Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Gamma

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Bjpsych Open|December 5, 2024
Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samplesAurélie Delacrétaz, Marie Sadler, Franziska Gamma, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Therapeutic Drug Monitoring|June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric PatientsNicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
The Journal of Clinical Psychiatry|March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort StudyClaire Grosu, William Hatoum, Marianna Piras, et al.
Schizophrenia Research|July 10, 2024
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal studyMarianna Piras, Iris Popovic, Setareh Ranjbar, et al.
Translational Psychiatry|November 15, 2024
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohortMarianna Piras, Jue Lin, Marie Catherine Sadler, et al.
The Journal of Clinical Psychiatry|April 3, 2020
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in SwitzerlandCéline Dubath, Aurélie Delacrétaz, Anaïs Glatard, et al.
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Bjpsych Open|December 5, 2024
Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samplesAurélie Delacrétaz, Marie Sadler, Franziska Gamma, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Therapeutic Drug Monitoring|June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric PatientsNicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
The Journal of Clinical Psychiatry|March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort StudyClaire Grosu, William Hatoum, Marianna Piras, et al.
Schizophrenia Research|July 10, 2024
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal studyMarianna Piras, Iris Popovic, Setareh Ranjbar, et al.
Translational Psychiatry|November 15, 2024
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohortMarianna Piras, Jue Lin, Marie Catherine Sadler, et al.
The Journal of Clinical Psychiatry|April 3, 2020
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in SwitzerlandCéline Dubath, Aurélie Delacrétaz, Anaïs Glatard, et al.
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Pageof 3